Back
ESC Premium Access

Summary - The expanding role of SGLT2i in cardiovascular risk, kidney disease and heart failure .

Session: Discussing the opportunities for SGLT2 in clinical cardiology
Topic: Renal Failure and Cardiovascular Disease
Speaker: Professor C. Wanner (Wuerzburg, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Organised by PACE-CME, supported with an educational grant provided by Boehringer-Ingelheim/Lilly
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speakers

Professor Christoph Wanner

University Hospital Wuerzburg, Wuerzburg (Germany)
10 presentations
1 follower

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
103 presentations
6 followers

2 more presentations in this session

Introduction

Speaker: Professor T. Luescher (London, GB)

Access
Slides
Video
Like
Thumbnail

Panel discussion

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR) Professor T. Luescher (London, GB) Professor C. Wanner (Wuerzburg, DE) Professor J. Deanfield (London, GB)

Access
Like
Thumbnail

Access the full session

Discussing the opportunities for SGLT2 in clinical cardiology

Speakers: Professor C. Wanner, Professor F. Zannad, Professor T. Luescher, Professor F. Zannad, Professor T. Luescher...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources